A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2002
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002083176A8 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080858A3 Use of kpv tripeptide for dermatological disorders
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2002000648A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/28/2002	WO2001092219A1 Glycinamides
11/28/2002	WO2001092214A1 Carbamic acid esters as inhibitors of factor xa
11/28/2002	WO2001089542A3 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/28/2002	WO2001082897A3 Liposome drug delivery
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/28/2002	US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002	US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002	US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002	US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002	US20020177586 Method for treating fibrotic diseases or other indications ID
11/28/2002	US20020177581 Novel anti-inflammatory androstane derivative
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020176902 Synergistic proteoglycan compositions for treatment of inflammatory diseases
11/28/2002	US20020176891 Topical gel delivery system
11/28/2002	US20020176888 Oral dosage forms
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176872 Pain treatment by peripheral administration of a neurotoxin
11/28/2002	US20020176842 A dosage form comprising an ionizable active ingredient and an unloaded ion exchange resin, coated with a permeable membrane; drug release and absorption depending on the conditions under which the membrane dissolves
11/28/2002	DE10141650C1 Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
11/28/2002	DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2448174A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	CA2447940A1 Urazole compounds useful as anti-inflammatory agents
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447231A1 Methods for inhibiting angiogenesis
11/28/2002	CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002	CA2446801A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446049A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	CA2445789A1 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002	CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	CA2427619A1 Pharmaceutically active isoindoline derivatives
11/28/2002	CA2410628A1 Carbamic acid esters
11/28/2002	CA2410627A1 Glycinamides
11/28/2002	CA2410391A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/27/2002	EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002	EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002	EP1260212A1 Cosmetic composition
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259621A2 Lipid metabolism enzymes
11/27/2002	EP1259618A2 Human enzyme molecules
11/27/2002	EP1259616A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders
11/27/2002	EP1259611A2 G-protein coupled receptors
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259520A2 Novel purines
11/27/2002	EP1259515A2 Thienopyridine derivatives and their use as anti-inflammatory agents
11/27/2002	EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002	EP1259508A1 Novel biarylcarboxamides
11/27/2002	EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002	EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002	EP1259495A2 Indane derivatives and their use as cell adhesion inhibitors
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1259486A1 Pyridine-amidines as modulators of p38 map kinase
11/27/2002	EP1259292A2 Therapeutic agents
11/27/2002	EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002	EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002	EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002	EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002	EP1259236A1 Tyrosine kinase inhibitors
11/27/2002	EP1259235A1 Tyrosine kinase inhibitors
11/27/2002	EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002	EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002	EP1259120A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
11/27/2002	EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002	EP1073639B1 Quinoline derivatives
11/27/2002	EP1001934B1 Indole compounds as cox-2 inhibitors
11/27/2002	EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002	EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002	EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation

1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 1272